Cargando…
IAP antagonist GDC-0917 is more potent than Debio1143 in promoting cell death, c-IAP1 degradation and tumor growth inhibition
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9519744/ https://www.ncbi.nlm.nih.gov/pubmed/36171193 http://dx.doi.org/10.1038/s41419-022-05283-w |
| _version_ | 1784799469149093888 |
|---|---|
| author | Alicke, Bruno Varfolomeev, Eugene Lee, Shi Hui Kaylee Frommlet, Alexandra Ubhayakar, Savita Quinn, John G. Fairbrother, Wayne J. Jones, Robert Gould, Stephen E. Vucic, Domagoj |
| author_facet | Alicke, Bruno Varfolomeev, Eugene Lee, Shi Hui Kaylee Frommlet, Alexandra Ubhayakar, Savita Quinn, John G. Fairbrother, Wayne J. Jones, Robert Gould, Stephen E. Vucic, Domagoj |
| author_sort | Alicke, Bruno |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9519744 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-95197442022-09-30 IAP antagonist GDC-0917 is more potent than Debio1143 in promoting cell death, c-IAP1 degradation and tumor growth inhibition Alicke, Bruno Varfolomeev, Eugene Lee, Shi Hui Kaylee Frommlet, Alexandra Ubhayakar, Savita Quinn, John G. Fairbrother, Wayne J. Jones, Robert Gould, Stephen E. Vucic, Domagoj Cell Death Dis Comment Nature Publishing Group UK 2022-09-28 /pmc/articles/PMC9519744/ /pubmed/36171193 http://dx.doi.org/10.1038/s41419-022-05283-w Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Comment Alicke, Bruno Varfolomeev, Eugene Lee, Shi Hui Kaylee Frommlet, Alexandra Ubhayakar, Savita Quinn, John G. Fairbrother, Wayne J. Jones, Robert Gould, Stephen E. Vucic, Domagoj IAP antagonist GDC-0917 is more potent than Debio1143 in promoting cell death, c-IAP1 degradation and tumor growth inhibition |
| title | IAP antagonist GDC-0917 is more potent than Debio1143 in promoting cell death, c-IAP1 degradation and tumor growth inhibition |
| title_full | IAP antagonist GDC-0917 is more potent than Debio1143 in promoting cell death, c-IAP1 degradation and tumor growth inhibition |
| title_fullStr | IAP antagonist GDC-0917 is more potent than Debio1143 in promoting cell death, c-IAP1 degradation and tumor growth inhibition |
| title_full_unstemmed | IAP antagonist GDC-0917 is more potent than Debio1143 in promoting cell death, c-IAP1 degradation and tumor growth inhibition |
| title_short | IAP antagonist GDC-0917 is more potent than Debio1143 in promoting cell death, c-IAP1 degradation and tumor growth inhibition |
| title_sort | iap antagonist gdc-0917 is more potent than debio1143 in promoting cell death, c-iap1 degradation and tumor growth inhibition |
| topic | Comment |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9519744/ https://www.ncbi.nlm.nih.gov/pubmed/36171193 http://dx.doi.org/10.1038/s41419-022-05283-w |
| work_keys_str_mv | AT alickebruno iapantagonistgdc0917ismorepotentthandebio1143inpromotingcelldeathciap1degradationandtumorgrowthinhibition AT varfolomeeveugene iapantagonistgdc0917ismorepotentthandebio1143inpromotingcelldeathciap1degradationandtumorgrowthinhibition AT leeshihuikaylee iapantagonistgdc0917ismorepotentthandebio1143inpromotingcelldeathciap1degradationandtumorgrowthinhibition AT frommletalexandra iapantagonistgdc0917ismorepotentthandebio1143inpromotingcelldeathciap1degradationandtumorgrowthinhibition AT ubhayakarsavita iapantagonistgdc0917ismorepotentthandebio1143inpromotingcelldeathciap1degradationandtumorgrowthinhibition AT quinnjohng iapantagonistgdc0917ismorepotentthandebio1143inpromotingcelldeathciap1degradationandtumorgrowthinhibition AT fairbrotherwaynej iapantagonistgdc0917ismorepotentthandebio1143inpromotingcelldeathciap1degradationandtumorgrowthinhibition AT jonesrobert iapantagonistgdc0917ismorepotentthandebio1143inpromotingcelldeathciap1degradationandtumorgrowthinhibition AT gouldstephene iapantagonistgdc0917ismorepotentthandebio1143inpromotingcelldeathciap1degradationandtumorgrowthinhibition AT vucicdomagoj iapantagonistgdc0917ismorepotentthandebio1143inpromotingcelldeathciap1degradationandtumorgrowthinhibition |